Martin Lauriot Prévost

Founder at Ozyme SAS

Health Technology

Profile

Martin Lauriot Prévost is the founder and current Chairman of Ozyme SAS, which is founded in 1984.
He is also currently a Member-Supervisory Board at Nosopharm SAS.

Martin Lauriot Prévost active positions

Companies	Position	Start
Ozyme SAS Ozyme SAS BiotechnologyHealth Technology Ozyme SAS is a distributor of reagents, instrumentation, and services in the fields of cellular biology, immunology, and molecular biology. The private company is based in Montigny-le-Bretonneux, France. and has subsidiaries in France. The French company was founded in 1984 by Martin Lauriot Prévost.	Founder	1983-12-31
Nosopharm SAS Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France.	Director/Board Member	-

All active positions of Martin Lauriot Prévost

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Lauriot Prévost's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Ozyme SAS Ozyme SAS BiotechnologyHealth Technology Ozyme SAS is a distributor of reagents, instrumentation, and services in the fields of cellular biology, immunology, and molecular biology. The private company is based in Montigny-le-Bretonneux, France. and has subsidiaries in France. The French company was founded in 1984 by Martin Lauriot Prévost.	Health Technology
Nosopharm SAS Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France.	Health Technology